Belgium CT Market: Modernisation Strengthened by Tertiary Networks and Private-Led Capacity
Belgium is entering a new phase of CT modernization as national reform plans for 2024 and 2025 focus on faster diagnostics as well as improved regional access. Rising trauma, cardiac disease, and cancer workloads increase reliance on high-resolution CT across both emergency as well as specialty pathways. The Federal Health Technology Plan continues to push for digital imaging upgrades, AI-supported decision tools, and lifecycle-based equipment renewal. These policies respond to increasing exam volumes in key provinces that depend on CT for acute care and complex case evaluation.
As per Hospital Intel Suite (HiS), tertiary hospitals account for the clear majority of installed systems and anchor high-complexity imaging in Antwerp, Brussels, Hainaut, Oost-Vlaanderen, and West-Vlaanderen. Private hospitals maintain far higher penetration than public institutions and drive most new installations, especially within large metropolitan corridors. University networks offer advanced subspecialty capability, while secondary hospitals contribute only a limited share, creating regional dependence on larger centers. Lower-density provinces show far weaker CT presence, resulting in heavier referral pressure and longer travel routes for advanced imaging.
These structural patterns are now shaping Belgium’s next modernization cycle. High-volume tertiary and university centers continue to prioritize faster spectral CT systems for trauma, oncology, and cardiac diagnostics. Regions with uneven penetration are moving toward stable, dose-efficient platforms designed to manage rising general imaging volumes. The private sector is accelerating refresh activity as older units approach replacement age, while public networks focus on strengthening state hospitals in provinces with limited access. This alignment of policy, demand, and infrastructure creates a defined growth opportunity for high-performance CT solutions supporting rapid emergency care, streamlined oncologic staging, and balanced regional access across Belgium.
